Taking the Plunge Elizabeth E. Garrard, PharmD, RPh The pharmaceutical industry and its regulators have been slow to adopt social media as a means for interacting with consumers. Overcoming the challenges that this vast pool of patient opinions poses can … MORE >
Social Media and Post-Marketing Drug Safety By Elizabeth E. Garrard, PharmD, RPh Download article here >> The online phenomenon of social media has the potential to advance health literacy, safety and transparency in pharma, although potential pitfalls and liabilities have … MORE >
Drug safety has become a hot topic—driven by a myriad of safety issues that have emerged and ever-increasing regulatory pressure to detect risks early. Simultaneously, changes in the economy and a tightening margin in the pharmaceutical world have pharma companies large and small focused on ways to make every dollar count. So how do you keep safety as a top priority while still controlling costs? MORE >
We have all experienced the typical chain of reactions to lifechanging events: initial surprise coupled with some denial, eventually leading to honest reassessment and a straightforward confrontation with reality. The pharmaceutical industry is definitely having its fair share of lifechanging events lately that are engendering such reactions. MORE >
With a focus on helping clients put in place comprehensive safety plans, she discusses the challenges pharma companies face with product submission an how they can improve their odds of success. MORE >
